Skip to content
  • Saturday, 15 August 2026
  • 1:08 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • US Life Sciences Investment Woes Leave Nation Vulnerable as China Cultivates Future Big Pharma Competitors
Pharmaceutical R&D

US Life Sciences Investment Woes Leave Nation Vulnerable as China Cultivates Future Big Pharma Competitors

Teuku Ryan Jun 25, 2026 0

San Diego, CA – The landscape of global biopharmaceutical innovation is undergoing a significant shift, with concerns mounting among investors…

Read More
Environmental & Analytical Chemistry

Why some brain cells are particularly vulnerable to multiple sclerosis

Abdurrohim Arsyad May 9, 2026 0

The enduring mission of Science News, established in the nascent years of the 20th century, continues to serve as a…

Read More
Groundbreaking Drug Screening Platform Developed to Combat Neurological and Psychiatric Diseases by Targeting Protein Expression ImbalancesRIKEN Physicists Pioneer Robust One-Way Quantum Synchronization of Phonons to Overcome Environmental Noise and Fabrication DefectsIndiana University School of Medicine Scientists Pioneer Advanced Multiplex Imaging Technique to Map the Mouse Bone Marrow MicroenvironmentEli Lilly and Ascidian Therapeutics Forge Strategic Alliance to Pioneer Novel Genetic Medicines for Kidney Diseases
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ